2021
DOI: 10.1080/14737159.2021.1919087
|View full text |Cite
|
Sign up to set email alerts
|

Fetal screening and whole genome sequencing: where are the limits?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2021
2021
2022
2022

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 15 publications
(10 reference statements)
0
1
0
Order By: Relevance
“…However, we should know that in the study they have considered anyone performing a secondary (supplementary) test, as being the result of positive screening in the primary prenatal screening test, while many of these cases were not positive with the national guidelines. The correct execution of the current national screening protocols leads to a false positive rate (FPR) of 5%, which is considered a standard value in terms of global statistics (4). Also, the claimed rate of invasive tests in Iran is within the global norms.…”
mentioning
confidence: 99%
“…However, we should know that in the study they have considered anyone performing a secondary (supplementary) test, as being the result of positive screening in the primary prenatal screening test, while many of these cases were not positive with the national guidelines. The correct execution of the current national screening protocols leads to a false positive rate (FPR) of 5%, which is considered a standard value in terms of global statistics (4). Also, the claimed rate of invasive tests in Iran is within the global norms.…”
mentioning
confidence: 99%